MITSUBISHI PHARMA CORPORATION
Patent Owner
Stats
- 65 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Oct 12, 2017 most recent publication
Details
- 65 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,064 Total Citation Count
- Jun 05, 1980 Earliest Filing
- 160 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8324283 Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcoholAug 11, 08Dec 04, 12[A61K, A01N]
7211596 Stable high-concentration injection containing pyrazolone derivativeMay 09, 02May 01, 07[A61K]
7198921 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced therebyMay 16, 01Apr 03, 07[C12P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0217,723 Pharmaceutical Composition Combining Tenatoprazole and an Anti-Inflammatory AgentAbandonedMar 25, 13Aug 22, 13[A61K]
2012/0122,919 PHARMACEUTICAL COMPOSITION COMBINING TENATOPRAZOLE AND A HISTAMINE H2-RECEPTOR ANTAGONISTAbandonedNov 15, 11May 17, 12[A61K, A61P]
2011/0152,314 USE OF TENATOPRAZOLE FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASEAbandonedFeb 25, 11Jun 23, 11[A61K, A61P]
2010/0048,518 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agentAbandonedOct 27, 09Feb 25, 10[A61K, A61P]
7507743 Substituted 8′-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one derivativesExpiredOct 02, 07Mar 24, 09[A61K, A61P]
2009/0005,392 CRYSTAL OF 6-[4-(4-PYRIDYLAMINO) PHENYL]-4,5-DIHYDRO-3(2H-PYRIDAZINONE HYDROCHLORIDE TRIHYDRATEAbandonedFeb 11, 08Jan 01, 09[A61K, C07D, A61P]
2008/0318,980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORSAbandonedAug 20, 08Dec 25, 08[A61K, A61P]
7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivativesExpiredMay 16, 07Dec 16, 08[A61K]
7462621 Use of substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives as therapeutic agentsExpiredApr 05, 07Dec 09, 08[C07D]
7452897 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseasesExpiredMar 29, 07Nov 18, 08[A61K]
7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3.beta. inhibitorsExpiredFeb 26, 03Sep 30, 08[C07D]
7393853 Use of substituted 8-Perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives as therapeutic agentsExpiredApr 04, 07Jul 01, 08[A61K]
7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disordersExpiredSep 19, 02Jun 17, 08[A61K]
7312239 Medicament for prevention and/or therapy of arterial wall disorderExpiredAug 18, 03Dec 25, 07[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.